​Germany–Oxford Life Sciences Innovation Roundtable

​🧬 Join us for a curated roundtable bringing together German life sciences founders and key players from the Oxford ecosystem on June 5th at the Oxford Science Park (The Magdalen Centre).

​The event is designed to foster meaningful connections and conversations between founders expanding into the UK market and Oxford-based players. The format encourages open exchange, collaboration opportunities, and cross-border relationship building.

​The event is co-organised by Oxford Science Park, Proximo Ventures, and German Accelerator.

​What to expect

​🔬 Discover emerging technologies and high-potential founding teams from Germany
🤝 Connect and discuss collaboration opportunities in advancing cross-border innovation
🌍 Exchange insights on scaling and collaborating across Germany and the UK
🍷 Informal networking, lunch, and conversation-driven discussions

​Event Details

​📍 The Oxford Science Park, The Magdalen Centre, Robert Robinson Avenue, OX4 4GA
📅 June 5, 2026
🕖 11:00–13:00

​About German Accelerator

​German Accelerator supports high-potential German startups and scale-ups in expanding internationally through tailored programs and direct access to global innovation ecosystems. The program is run by Start2 Group and financed by the German Federal Ministry for Economic Affairs and Energy (BMWE).

​Meet the German life sciences startups:

​AATec Medical: Develops next-generation biotherapeutics for respiratory inflammatory diseases such as COPD, asthma, and airway infections.

​ACCURIDS: Provides a SaaS platform that transforms fragmented medicinal product data into actionable intelligence for pharmaceutical companies.

​brainjo: Develops evidence-based VR therapy solutions for ADHD and other mental health conditions.

​hema.to: Builds AI-powered software that automates flow cytometry analysis for clinical hematology laboratories.

​PL BioScience: Produces human platelet lysate solutions to enable safe and scalable cell and gene therapies.

​Puraite: Uses explainable AI to automate systematic literature reviews and evidence synthesis for pharma and research organizations.

​QuantView: Develops advanced MRI technology for early cancer detection and treatment monitoring through metabolic imaging.